.jpg)
![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
FDA approves Dupixent for hives, rejects new Eylea dosing schedule
The FDA made two decisions on Regeneron’s best-selling drugs Friday, handing down one approval and one rejection. The approval came for Dupixent, the megablockbuster Regeneron develops and sells with Sanofi. Regulators approved it to treat ...
The FDA made two decisions on Regeneron’s best-selling drugs Friday, handing down one approval and one rejection.
The approval came for Dupixent, the megablockbuster Regeneron develops and sells with Sanofi. Regulators approved it to treat ...
